AzTrials
AzTrials

Infant BehaviorNCT05903053

Pilot Study: A Telehealth Intervention for Caregivers of Infants With Early Signs of ADHD

A study testing Early Self-Regulation Intervention in people with Infant Behavior and Infant Development, run by University of California, Davis at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This project will build on the investigators' work focused on early identification of ADHD, expanding to the development of a feasibility/pilot intervention involving early intervention for such infants. Read more about this study

Who is it for?
Ages 12 to 18 monthsHealthy volunteers can take part
Conditions the study is for
Infant Behavior, Infant Development, Self-Control
What is being tested?
Early Self-Regulation Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
8 participants
Where
1 siteUnited States
Study dates
1 Aug 2023to 31 Oct 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 18 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Infants must be enrolled in UC Davis IRB protocol #1077801 and
  • Be between the ages of 12-18 months at the time of intake assessment,
  • Have a first-degree relative with ADHD (parent or sibling),
  • Exhibit early symptoms of ADHD based on examiner observation as indicated by at least 1 subscale on the Behavior Rating Inventory for Children (BRIC) rated 4 or higher,
  • Expression of at least 1 concern about the child's behavior/development by the caregiver.
  • Caregivers must:
Show all 9Show fewer
  • Be identified as the infants' primary caregivers,
  • Be English-speaking,
  • Have access to wired or wireless network technology to access the internet in their homes.

Who cannot join

  • Birth before 33 weeks' gestation,
  • Known genetic disorders (e.g., fragile X syndrome, Tuberous Sclerosis),
  • History of traumatic brain injury,
  • Severe visual, hearing, or motor impairment or fragile health condition that would prevent the child from validly participating in the assessment procedures, and
  • A caregiver may be excluded from participation if the caregiver is already engaging in the majority of all possible caregiver treatment target behaviors at therapeutic levels during intake (Fidelity of Implementation scores of 80% or higher on each caregiver target behavior).

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UC Davis MIND Institute

    Sacramento, California, 95817

Other trials in United States

About this study

This project will build on the investigators' work focused on early identification of ADHD, expanding to the development of a feasibility/pilot intervention involving early intervention for such infants. The investigators will evaluate the effectiveness of a telehealth-delivered, caregiver-implemented supportive intervention for infants/toddlers show early self-regulation difficulties.

Read the detailed description

This project will build on the investigators' work focused on early identification of ADHD, expanding to the development of a feasibility/pilot intervention involving early intervention for such infants. The investigators will evaluate the effectiveness of a telehealth-delivered, caregiver-implemented supportive intervention for infants/toddlers show early self-regulation difficulties.

Primary aims of this study include:

  1. Develop and test a telehealth-delivered, parent-mediated intervention targeting infant/toddler self-regulation in natural contexts, to aid both infant and caregiver learning.
  2. Identify, develop, and test measures/observations that can be gathered via telehealth contacts to assess ongoing change in infant and caregiver behavior over the course of the study.
  3. Test acceptability and satisfaction of the intervention and the telehealth delivery for families receiving the intervention.
Being tested
Early Self-Regulation Intervention
Medical subject headings
Infant Behavior, Self-Control, Emotional Regulation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Early Self-Regulation InterventionBehavioural

    Participants enrolled in a separate protocol (UC Davis IRB ID#1077801) will be invited to participate upon meeting eligibility criteria. All participants will receive the intake and exit assessment battery, with the intake assessment battery being completed as part of IRBNet ID#1077801. A multiple baseline design across participants will be used with varying introduction of treatment elements for a subset of enrolled intervention participants. An intense intervention phase will follow the baseline phase in which 45-60 minute intervention sessions will occur two times per week for approximately 4-6 weeks for a total of 8 sessions. At the conclusion of the intense intervention phase, coaches will provide "booster" sessions once weekly for a month (4 sessions total).

Study groups in NCT05903053
Study groupRoleWhat they receive
Telehealth InterventionExperimentalA multiple baseline design across subjects will be used with varying introduction of treatment elements. Baseline periods will be 3, 5, and 7 sessions with the baseline period of 3 and 5 sessions repeated twice for subsequent participants. An intense intervention phase will follow the baseline phase in which 45-60 minute treatment sessions will occur twice per week over the course of 4-6 weeks for a total of 8 sessions. Each week during the intense intervention phase, caregiver coaches will introduce a new treatment technique to the caregiver and allow for caregiver practice with immediate feedback. At the conclusion of the intense intervention phase, coaches will provide "booster" sessions with the caregivers once weekly for 1 month (4 sessions total).
Receives: Behavioral: Early Self-Regulation Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Child attention regulation

    Child duration of orienting during the intervention sessions will be coded from video using a standardized behavioral coding paradigms developed within the investigators' lab.

    Measured: Change from baseline at intervention session #8 (end of week 4)

  2. Child inhibitory control

    Child frequency of grabbing behavior during the intervention sessions will be coded from video using a standardized behavioral coding paradigms developed within the investigators' lab.

    Measured: Change from baseline at intervention session #8 (end of week 4)

  3. Child emotion regulation

    Child frequency of negative affect during the intervention sessions will be coded from video using a standardized behavioral coding paradigms from the Lab-TAB. Higher levels equate to more negative affect.

    Measured: Change from baseline at intervention session #8 (end of week 4)

  4. Caregiver Fidelity of Implementation

    Caregiver fidelity of implementation (FI) of the intervention will be coded from 3-minute caregiver-child dyad intervention video probes to determine caregivers' FI of intervention techniques over the course of the study. This involves having experts in the intervention rate caregiver use of each of the intervention strategies on a 1-5 Likert rating scale, with a code of "1" meaning the caregiver did not implement the technique throughout the session and a code of "5" meaning the caregiver implemented the technique correctly throughout the session. An FI score of 80% (determined by total caregiver points out of the maximum possible points multiplied by 100) or higher for the entire intervention session indicates success in caregivers' FI of intervention techniques. Higher values represent greater fidelity.

    Measured: Change from baseline at intervention session #8 (end of week 4)

  5. Parent Satisfaction Rating

    This is a measure of social validity, or acceptability, of the experimental treatment, to caregivers. This tool allows caregivers to rate the ease of implementation in the home and their opinions concerning treatment utility. Higher scores indicate greater satisfaction with the intervention.

    Measured: Immediately following session #8 (end of week 4)

  6. Working Alliance Scale for Interventions with Children

    This will be used to describe the response of the families to the intervention in terms of perceived alliance with the coach. Higher scores equate to more positive working alliance.

    Measured: Immediately following session #8 (end of week 4)

  7. Lab-TAB Toy Retraction Task

    This task involves a standardized press for negative affect. The duration of negative affect during the task will be coded from video. Higher levels equate to more negative affect.

    Measured: Change from baseline at intervention session #8 (end of week 4)

Secondary outcomes (2)
  1. Parent concerns interview

    The total number of parent concerns about child behavior and development will be examined. Fewer concerns reflects more positive outcomes.

    Measured: Change from baseline at intervention session #8 (end of week 4)

  2. Infant/Early Childhood Behavior Questionnaire (IBQ/ECBQ) - Effortful control

    The effortful control composite scores derived from these temperament rating scales will be examined. Higher scores reflect greater effortful control (i.e., more positive outcome).

    Measured: Change from baseline at intervention session #8 (end of week 4)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jun 2023
  2. Study start1 Aug 2023
  3. Primary completion31 Oct 2026 (estimated)
  4. Study completion31 Oct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
8 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05903053
Sponsor's protocol ID
2003351
Status last verified
Dec 2025
First submitted
6 Mar 2023
Last updated
15 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Early Self-Regulation Intervention in people with Infant Behavior and Infant Development, run by University of California, Davis at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 15 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Child attention regulation (time frame: Change from baseline at intervention session #8 (end of week 4)). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Dec 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in